Sotera Health Company SHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23B | 1.22B | 1.19B | 1.16B | 1.15B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23B | 1.22B | 1.19B | 1.16B | 1.15B |
| Cost of Revenue | 558.01M | 547.66M | 531.97M | 518.08M | 506.40M |
| Gross Profit | 671.74M | 668.51M | 657.17M | 645.53M | 643.98M |
| SG&A Expenses | 212.26M | 212.07M | 212.42M | 205.17M | 200.98M |
| Depreciation & Amortization | 12.07M | 12.16M | 18.44M | 30.74M | 43.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 782.34M | 771.89M | 762.83M | 753.99M | 750.47M |
| Operating Income | 447.41M | 444.29M | 426.31M | 409.63M | 399.91M |
| Income Before Tax | 274.89M | 264.10M | 204.94M | 147.51M | 121.97M |
| Income Tax Expenses | 101.42M | 100.62M | 87.14M | 69.56M | 66.55M |
| Earnings from Continuing Operations | 173.47 | 163.48 | 117.80 | 77.95 | 55.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 173.47M | 163.48M | 117.80M | 77.95M | 55.43M |
| EBIT | 447.41M | 444.29M | 426.31M | 409.63M | 399.91M |
| EBITDA | 579.18M | 571.88M | 555.45M | 548.66M | 546.86M |
| EPS Basic | 0.61 | 0.57 | 0.41 | 0.27 | 0.20 |
| Normalized Basic EPS | 0.70 | 0.68 | 0.62 | 0.57 | 0.52 |
| EPS Diluted | 0.60 | 0.57 | 0.41 | 0.27 | 0.19 |
| Normalized Diluted EPS | 0.69 | 0.67 | 0.62 | 0.57 | 0.52 |
| Average Basic Shares Outstanding | 1.14B | 1.14B | 1.14B | 1.14B | 1.13B |
| Average Diluted Shares Outstanding | 1.15B | 1.15B | 1.15B | 1.14B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |